Roka Bioscience Inc (ROKA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -30,787 | -36,600 | -32,230 | -29,578 | -23,246 |
| Depreciation Amortization | 5,833 | 6,583 | 4,248 | 2,437 | 2,045 |
| Income taxes - deferred | N/A | -49 | 3,145 | -3,127 | 9 |
| Accounts receivable | -207 | -122 | -220 | -187 | -30 |
| Other Working Capital | -1,425 | 2,083 | -3,428 | -2,050 | -4,699 |
| Other Operating Activity | 3,784 | 4,359 | 4,970 | 5,053 | -1,853 |
| Operating Cash Flow | $-22,802 | $-23,746 | $-23,515 | $-27,452 | $-27,774 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 12,633 | 20,177 | -49,759 | N/A | N/A |
| PPE Investments | -217 | -100 | -198 | -3,410 | -5,929 |
| Other Investing Activity | 0 | 0 | -10,500 | 0 | 0 |
| Investing Cash Flow | $12,416 | $20,077 | $-60,457 | $-3,410 | $-5,929 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 4,950 | N/A | 4,672 | N/A |
| Debt Repayment | -4,000 | -5,350 | N/A | 0 | N/A |
| Common Stock Issued | N/A | 78 | 58,854 | -179 | 4 |
| Other Financing Activity | 19,777 | -71 | -107 | 41,783 | 20,000 |
| Financing Cash Flow | $15,777 | $-393 | $58,747 | $46,276 | $20,004 |
| Beginning Cash Position | 3,441 | 7,503 | 32,728 | 17,314 | 31,013 |
| End Cash Position | 8,832 | 3,441 | 7,503 | 32,728 | 17,314 |
| Net Cash Flow | $5,391 | $-4,062 | $-25,225 | $15,414 | $-13,699 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,802 | -23,746 | -23,515 | -27,452 | -27,774 |
| Capital Expenditure | -277 | -171 | -258 | -3,470 | -5,929 |
| Free Cash Flow | -23,079 | -23,917 | -23,773 | -30,922 | -33,703 |